A second opinion for testicular tumors improves every fifth treatment plan
Another discrepancy in therapy planning, which often has to be corrected by the experts in the testicular tumor second opinion project, is adjuvant therapy for testicular tumors in stage 1, explains the head of urology at the Helios Klinikum Berlin-Buch. For several years now, the current guidelines have no longer recommended two cycles, but only one cycle with cisplatin, etoposide and bleomycin (PEB).
"We knew that the quality of care for testicular tumors, which are rare tumor entity, varies greatly from region to region, ”says Schrader. Experience with advanced tumors is often limited. “On the other hand, it was not politically wanted to treat these tumors at few centers. Today we know that good compromise has been achieved with our central network, ”continues the urologist.
Obtaining and creating the second opinion as well as the follow-ups are carried out by those insured by the Techniker Krankenkasse and the Hanseatische Krankenkasse reimbursed.
The testicular tumor second opinion project has also established itself in other specialist disciplines. “The Charité, for example, offers one with our software platform,” says Schrader. An expansion to other diseases has also been initiated in urology.
Deutsches Ärzteblatt print
It is particularly important for him to have second expertise on rare tumors in which individual doctors have very little experience. “In urology, this undoubtedly affects the rare penile cancer. We will shortly start another second opinion procedure for this entity, ”announces the DGU and Congress President Oliver W.Hook mountain. The director of the Clinic and Polyclinic for Urology at the Rostock University Medical Center has set up the German penile cancer registry in the Hanseatic city and developed the prototype for the national penile carcinoma second opinion procedure.